LEO Pharma US is a global company committed to improving the quality of life for individuals with skin conditions, as well as their families and communities. Since its establishment in 1908, and with majority ownership by the LEO Foundation, LEO Pharma has dedicated substantial resources to advancing dermatological science. Today, the company offers an extensive range of therapies catering to various disease severities, aiming to elevate the standard of care in dermatology. LEO Pharma US' dedication to ensuring factual and non-promotional content is evident in its social media principles and privacy policy, exemplifying its commitment to ethical and regulatory compliance.
For further information, visit www.leo-pharma.us and follow on Twitter @LEOPharmaUS.
There is no investment information
No recent news or press coverage available for LEO Pharma US.